German drugmaker Bayer said it will invest about 2 billion euros ($2.23 billion) in pharmaceutical manufacturing sites over the next three years, mainly to support the production of biotech drugs, as well as cell and gene therapies.

4gi.tv
German drugmaker Bayer said it will invest about 2 billion euros ($2.23 billion) in pharmaceutical manufacturing sites over the next three years, mainly to support the production of biotech drugs, as well as cell and gene therapies.
Copyright © 2022. All Rights Reserved.